Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers Paris, France, and Houston, Texas, September 12, 2024. As part of its effort to ...

Would-be dads taking drugs to stop their epilepsy seizures—and valproate in particular—should be largely reassured that the available evidence on the developmental risks to their offspring doesn’t ...

Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a phase 3 study showing a significantly greater proportion ...

Aude Bandini has received funding from the Arts and Humanities Research Council. Jean-Philippe Drouin-Chartier has received research funding from Dairy Farmers of Canada and the Weston Family ...

A phase 3 study of the novel antibody-drug conjugate tusamitamab ravtansine in advanced nonsquamous NSCLC yielded disappointing results, but hope for CEACAM5 as a target remains.

Following his inauguration as President of Nigeria in May 2023, Bola Tinubu announced in his inaugural address that his ...

GlaxoSmithKline Holdings Inc., Pfizer Inc., Sanofi-Aventis U.S. LLC, and Sanofi US Services Inc. as the defendants. GlaxoSmithKline, Pfizer and Sanofi argued in their motion to dismiss that the ...

Hoechst and Rhône-Poulenc Rorer were the two companies that merged to form Aventis. Despite Sanofi-Synthélabo’s size, the company found itself forced to partner with larger pharmaceutical ...

A False Claim Act whistleblower’s suit alleging that Sanofi Services Inc. and Sanofi-Aventis US LLC defrauded Medicaid by overcharging for insulin must be dismissed, for now, a California federal ...

Dr. Steve Caffé is an accomplished industry executive with over 25 years of expertise in global product development and ...